{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:04:07Z","timestamp":1790136247935,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bmcl.2020.127357","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T21:53:14Z","timestamp":1592517194000},"page":"127357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["MK-5204: An orally active \u03b2-1,3-glucan synthesis inhibitor"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9817-9568","authenticated-orcid":false,"given":"James M.","family":"Apgar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert R.","family":"Wilkening","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Dann L.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J.","family":"Wildonger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Sperbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L.","family":"Greenlee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Balkovec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy M.","family":"Flattery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George K.","family":"Abruzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Galgoci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Giacobbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Jo","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Liberator","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Misura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Motyl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Nielsen","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryann","family":"Powles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Racine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasminka","family":"Dragovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Kirwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Mamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kingsley","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Peel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2020.127357_b0005","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMra1315399","volume":"373","author":"Kullberg","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2020.127357_b0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1513\/pats.200510-110JH","volume":"3","author":"Kauffman","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.bmcl.2020.127357_b0015","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1517\/14656566.2013.805204","volume":"14","author":"Tragiannidis","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.bmcl.2020.127357_b0020","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/myc.12265","volume":"57","author":"Moriyama","year":"2014","journal-title":"Mycoses"},{"key":"10.1016\/j.bmcl.2020.127357_b0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tim.2010.02.004","volume":"18","author":"Denning","year":"2010","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.bmcl.2020.127357_b0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bmcl.2020.127357_b0035","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1080\/13543784.2017.1341488","volume":"26","author":"McCarthy","year":"2017","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.bmcl.2020.127357_b0040","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1586\/eri.09.18","volume":"7","author":"Pem\u00e1n","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.bmcl.2020.127357_b0045","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","volume":"125","author":"Pfaller","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.bmcl.2020.127357_b0050","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/QCO.0000000000000111","volume":"27","author":"Arendrup","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.bmcl.2020.127357_b0055","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0966-842X(03)00117-3","volume":"11","author":"Odds","year":"2003","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.bmcl.2020.127357_b0060","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1517\/13543784.12.8.1313","volume":"12","author":"Wiederhold","year":"2003","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.bmcl.2020.127357_b0065","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2217\/fmb.11.19","volume":"6","author":"Perlin","year":"2011","journal-title":"Future Microbiol"},{"key":"10.1016\/j.bmcl.2020.127357_b0070","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/AAC.41.11.2333","volume":"41","author":"Abruzzo","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2020.127357_b0075","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1021\/ja9944296","volume":"122","author":"Schwartz","year":"2000","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2020.127357_b0080","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/AAC.44.2.368-377.2000","volume":"44","author":"Onishi","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2020.127357_b0085","first-page":"333","volume":"23","author":"Pel\u00e1ez","year":"2000","journal-title":"Appl Microbiol"},{"key":"10.1016\/j.bmcl.2020.127357_b0090","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1016\/j.bmcl.2015.10.011","volume":"25","author":"Apgar","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2020.127357_b0095","unstructured":"Balkovec, J. M., Bouffard, F. A., Tse, B., Dropinski, J., Meng, D., Greenlee, M. L., Peel, M. R., Fan, W., Mamai, A., Liu, H., Li, K. PCT Intl. Patent Appl., WO 2,007,127,012 A1, 2007."},{"key":"10.1016\/j.bmcl.2020.127357_b0100","unstructured":"Greenlee, M. L., Wilkening, R., Apgar, J., Wildonger, K. J., Meng, D., Parker, D. L. PCT Intl. Patent Appl. WO 2,010,019,203 A1, 2010."},{"key":"10.1016\/j.bmcl.2020.127357_b0105","unstructured":"Greenlee, M. L., Wilkening, R., Apgar, J., Sperbeck, D., Wildonger, K. J., Meng, D., Parker, D. L., Pacofsky, G. J., Heasley, B. H., Mamai, A., Nelson, K. PCT Intl. Patent Appl. WO 2,010,019,204 A1, 2010."},{"key":"10.1016\/j.bmcl.2020.127357_b0110","unstructured":"DBA\/2 mice were treated orally (PO) or intraperitoneally (IP) with test compounds twice daily (bid) for two days after being challenged with C. albicans (MY1055). Four days after challenge, the kidneys from euthanized mice were removed and analyzed for colony forming units (CFUs) as described in reference 23. The CFUs \/ g of kidney from the groups of treated animals were compared to the CFUs \/ g of kidney from sham treated control animals."},{"key":"10.1016\/j.bmcl.2020.127357_b0115","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1128\/AAC.36.8.1648","volume":"36","author":"Bartizal","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2020.127357_b0120","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1021\/jm049828c","volume":"47","author":"Roppe","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2020.127357_b0125","first-page":"25","volume":"1988","author":"Hanna","year":"1857","journal-title":"Heterocyclic Chem"},{"key":"10.1016\/j.bmcl.2020.127357_b0130","doi-asserted-by":"crossref","first-page":"8772","DOI":"10.1021\/jo0156868","volume":"66","author":"Tang","year":"2001","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmcl.2020.127357_b0135","unstructured":"DBA\/2N mice were treated bid PO or IP for 7 days after being challenged with C. albicans (MY1055) at 2.44 x 104 CFU\/mouse. Seven days after challenge, kidneys were aseptically collected and analyzed as described in reference 23."},{"key":"10.1016\/j.bmcl.2020.127357_b0140","unstructured":"DBA\/2N mice were treated bid IP for 7 days after being challenged with A. fumigatus (MF5668) at 6.7 x 105 CFU\/mouse via IV delivery. The first treatment was delivered 15-30 minutes following the challenge and survival was monitored out to 21 days."}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X20304686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X20304686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:35:53Z","timestamp":1760772953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X20304686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":28,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0960894X20304686"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2020.127357","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MK-5204: An orally active \u03b2-1,3-glucan synthesis inhibitor","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2020.127357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"127357"}}